Home blood pressure during night-time sleep – a feasible treatment target for patients with hypertension: a proof-of-concept randomised controlled trial
Open Access
- 14 February 2025
- journal article
- Published by Taylor & Francis in Journal of Pharmaceutical Policy and Practice
- Vol. 18 (1) , 2463435
Abstract
This trial assessed the feasibility of titrating evening dosing of anti-hypertensive medications based on nighttime home blood pressure measurement (HBPM) readings in primary care for hypertensive (HT) patients. 78 patients with nocturnal HT and stage I daytime HT were randomly assigned in a 1:1 ratio to either nighttime HBPM measurements (intervention group) or daytime HBPM measurements (control group). Nighttime blood pressure (BP) was measured 3x per night for at least two nights over 1 week using an automatic and validated HBPM device. The intervention group and control group aimed to achieve systolic BP <120 mmHg on nocturnal HBPM and systolic BP <135 mmHg on daytime HBPM respectively. All patients were seen every four weeks and followed the same drug titration algorithm. The trial achieved a recruitment rate of 6.5 persons per month and a retention rate of 96.1%. In the intervention group, patients provided ≥6 (considered adequate) and ≥9 nighttime HBPM readings for 77.5% and 63.8% of their follow-ups, respectively. At 6-month, both groups had similar nighttime, 24-hour, and daytime BP on ambulatory BP monitoring, as well as similar numbers of non-dippers and healthcare utilisation. Most patients reported that they learned more from their HBPM nighttime readings and found the intervention well-tolerated. Adjusting evening dosage of anti-HT medications based on nighttime HBPM is a potential and feasible treatment approach for patients with nocturnal HT in primary care. This approach is well-accepted by patients and results in at least non-inferior BP control. Although titrating medications according to nighttime HBPM readings may improve nighttime BP, the small sample size limited statistical significance and the single-centre design restricted generalizability. Additionally, a few patients exhibited fair adherence to nighttime HBPM. Further randomised controlled trials are required to confirm that targeting nocturnal BP should be the primary treatment goal for HT.Keywords
Funding Information
- the Health and Medical Research Fund by HKSAR (18190461)
This publication has 29 references indexed in Scilit:
- Comparative effects of valsartan plus either cilnidipine or hydrochlorothiazide on home morning blood pressure surge evaluated by information and communication technology–based nocturnal home blood pressure monitoringThe Journal of Clinical Hypertension, 2018
- Comparative Effects of an Angiotensin II Receptor Blocker (ARB)/Diuretic vs. ARB/Calcium-Channel Blocker Combination on Uncontrolled Nocturnal Hypertension Evaluated by Information and Communication Technology-Based Nocturnal Home Blood Pressure Monitoring ― The NOCTURNE Study ―Circulation Journal, 2017
- The association between home vs. ambulatory night-time blood pressure and end-organ damage in the general populationJournal Of Hypertension, 2016
- Comparison of Acceptability of Traditional and Novel Blood Pressure Measurement MethodsAmerican Journal of Hypertension, 2015
- The effect of antihypertensive agents on sleep apnea: protocol for a randomized controlled trialTrials, 2014
- Nighttime Home Blood Pressure and the Risk of Hypertensive Target Organ DamageHypertension, 2012
- Development and psychometric evaluation of the Treatment Adherence Questionnaire for Patients with HypertensionJournal of Advanced Nursing, 2011
- How quickly should we titrate antihypertensive medication? Systematic review modelling blood pressure response from trial dataHeart, 2011
- Predictive Role of the Nighttime Blood PressureHypertension, 2011
- Effect of dosing time of angiotensin II receptor blockade titrated by self-measured blood pressure recordings on cardiorenal protection in hypertensives: the Japan Morning Surge-Target Organ Protection (J-TOP) studyJournal Of Hypertension, 2010